Amos Grünebaum: The Cost of Ideology in Fertility Treatments
Amos Grünebaum, Professor of Obstetrics and Gynecology Donald and Barbara Zucker School of Medicine, shared at on LinkedIn:
“IVF, ‘Natural’ Medicine, and the Cost of Ideology
When fertility care is framed as a moral project rather than a medical one, patients pay the price. A new JAMA Viewpoint examines how so-called ‘restorative reproductive medicine’ restricts access to IVF and other evidence-based treatments, not because they are unsafe, but because they conflict with ideology. In this piece, I unpack why denying effective care in the name of ‘natural’ medicine is neither ethical nor patient-centered, and why this debate matters far beyond infertility clinics.
More here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG